Clinical Trials Insight: 700012179
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2007
At a glance
- Drugs ZT 031 (Primary)
- Indications Menopause; Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Azelon Pharmaceuticals
- 19 Sep 2007 Primary endpoint reported at ASBMR by Zelos.
- 13 Feb 2007 Top-line results have been reported
- 16 Feb 2006 New trial record.